SEC Form 4 · accession 0001209191-15-082523
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
Nov 25, 2015
Accepted (ET)
Nov 30, 2015 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 25, 2015 | M | 5,000 | $2.35 | A | 112,775 | D | |
| Common StockF2,F1 | Nov 25, 2015 | S | 5,000 | $30.00 | D | 107,775 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $2.35 | Nov 25, 2015 | M | 5,000 | D | — | Mar 12, 2018 | Common Stock | 5,000 | 25,000 | D |
Explanation of responses
- F1Includes 277 shares acquired on November 13, 2015 through the Issuer's Employee Stock Purchase Plan.
- F2Shares sold pursuant to a 10b5-1 plan.
- F3Fully vested.